Analysis of DNA Adducts Formed in Vivo in Rats and Mice from 1,2-Dibromoethane, 1,2-Dichloroethane, Dibromomethane, and Dichloromethane Using HPLC/Accelerator Mass Spectrometry and Relevance to Risk Estimates
Authors:
- 2 October 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 20 (11) , 1594-1600
Abstract
Dihaloalkanes are of toxicological interest because of their high-volume use in industry and their abilities to cause tumors in rodents, particularly dichloromethane and 1,2-dichloroethane. The brominated analogues are not used as extensively but are known to produce more toxicity in some systems. Rats and mice were treated i.p. with 14C-dichloromethane, -dibromomethane, -1,2-dichloroethane, or -1,2-dibromoethane [5 mg (kg body weight)−1], and livers and kidneys were collected to rapidly isolate DNA. The DNA was digested using a procedure designed to minimize processing time, because some of the potential dihalomethane-derived DNA–glutathione (GSH) adducts are known to be unstable, and the HPLC fractions corresponding to major adduct standards were separated and analyzed for 14C using accelerator mass spectrometry. The level of liver or kidney S-[2-(N7-guanyl)ethyl]GSH in rats treated with 1,2-dibromoethane was ∼1 adduct/105 DNA bases; in male or female mice, the level was approximately one-half of this. The levels of 1,2-dichloroethane adducts were 10–50-fold lower. None of four known (in vitro) GSH–DNA adducts was detected at a level of >2/108 DNA bases from dibromomethane or dichloromethane. These results provide parameters for risk assessment of these compounds: DNA binding occurs with 1,2-dichloroethane but is considerably less than from 1,2-dibromoethane in vivo, and low exposure to dihalomethanes does not produce appreciable DNA adduct levels in rat or mouse liver and kidney of the doses used. The results may be used to address issues in human risk assessment.Keywords
This publication has 43 references indexed in Scilit:
- Workshop Overview: Reassessment of the Cancer Risk of Dichloromethane in HumansToxicological Sciences, 2006
- Mechanisms of Carcinogenicity of Methyl HalidesCritical Reviews in Toxicology, 1993
- Metabolic activation of carcinogensPharmacology & Therapeutics, 1992
- Ranking the potential carcinogenic hazards to workers from exposures to chemicals that are tumorigenic in rodents.Environmental Health Perspectives, 1987
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- 1,2-Dibromoethane (ethylene dibromide).Environmental Health Perspectives, 1983
- Pharmacokinetics and macromolecular interactions of ethylene dichloride in rats after inhalation or gavage*1Toxicology and Applied Pharmacology, 1982
- The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium I. Activation through conjugation with glutathion in vitroChemico-Biological Interactions, 1978
- Induction of Stomach Cancer in Rats and Mice by Halogenated Aliphatic FumigantsJNCI: Journal of the National Cancer Institute, 1973
- FATAL ETHYLENE DICHLORID POISONINGThe American Journal of the Medical Sciences, 1935